Today is World Rare Disease Day. This year's theme is ‘More Than You Can Imagine’, and it’s exactly right.
More than 300 million people worldwide live with a rare disease. More conditions than most of us have heard of. More years spent waiting for a diagnosis. More barriers between a patient and the treatment they need.
And still, only around 5% of rare diseases have approved treatments. This number is where the pharmaceutical industry has a responsibility.
Adalvo’s rare disease portfolio contains 22 therapies that span conditions across oncology, cardiovascular disease, immunology, and gastroenterology.
To us, no patient population is too small to matter.
Our focus on generics and specialty products means that when patent protection ends, we're ready to make access a reality rather than a privilege.
Rare doesn't mean forgotten. And access should never depend on price. To the patients, families, and caregivers living this reality today: we see you.
If you'd like to see our full portfolio of rare disease therapies, contact a member of the team today.